Key result
Higher Social Vulnerability Index was not significantly associated with cardiac pathology in the overall cohort, but was associated with increased odds of myocardial fibrosis (OR 2.37) among individuals without clinical heart failure.
Why the study?
Limited data exist regarding the potential role of social vulnerability and related physiologic stressors on tissue-level myocardial pathology.
Does higher Social Vulnerability Index associate with pathologic myocardial findings at autopsy?
Observational (n=853)
No
Does higher Social Vulnerability Index associate with pathologic myocardial findings at autopsy?
Higher social vulnerability is associated with increased odds of myocardial fibrosis at autopsy in individuals without known clinical heart failure, suggesting a potential link between social stressors and subclinical myocardial dysfunction.
Answers are grounded in this paper and cite their sources.
Higher SVI was associated with myocardial fibrosis absent clinical HF; leaves open whether targeting social vulnerability prevents subclinical cardiac pathology.
Background: Social vulnerability is an important determinant of cardiovascular health. Prior investigations have shown strong associations of social determinants of health with cardiovascular risk factors, imaging findings, and clinical events. However, limited data exist regarding the potential role of social vulnerability and related physiologic stressors on tissue-level pathology. Methods: We analyzed clinical data and linked autopsy reports from 853 decedent individuals who underwent autopsy from 4/6/2002 to 4/1/2021 at a large urban medical center. The mean age at death was 62.9 (SD = 15.6) and 49% of decedent individuals were men. The primary exposure was census-tract level composite social vulnerability index based on the Centers for Disease Control and Prevention Social Vulnerability Index (SVI). Individuals were geocoded to census tracts and assigned SVI accordingly. Four myocardial tissue-level outcomes from autopsy were recorded as present or absent: any coronary atherosclerosis, severe/obstructive coronary atherosclerosis, myocardial fibrosis, and/or myopericardial inflammation. Multivariable-adjusted logistic regression models were constructed with SVI as the primary exposure and covariates including age, sex, race, body mass index (BMI), diabetes, and hypertension. Additional analyses were performed stratified by clinical diagnoses of heart failure (HF) and coronary artery disease (CAD). Results: In the overall cohort, SVI was not associated with outcomes on cardiac pathology in multivariable-adjusted models. However, in stratified multivariable-adjusted analyses, higher SVI (higher social vulnerability) was associated with a higher odds of myocardial fibrosis among individuals without clinical diagnoses of HF. Conclusions: Higher indices of social vulnerability are associated with a higher odds of myocardial fibrosis at autopsy among individuals without known clinical diagnoses of HF. Potential pathophysiological mechanisms and implications for prevention/treatment of myocardial dysfunction require further study.
No takes yet. Share an insight, caveat, or question.
Sunderraj et al. (2021) conducted an observational in Decedent individuals undergoing autopsy (n=853). Social Vulnerability Index vs. Lower Social Vulnerability Index was evaluated on Myocardial fibrosis (overall cohort) (OR 1.45, 95% CI 0.85-2.46, p=0.17). Higher Social Vulnerability Index was not significantly associated with cardiac pathology in the overall cohort, but was associated with increased odds of myocardial fibrosis (OR 2.37) among individuals without clinical heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: